BUY Biocon Ltd — Motilal Oswal

Entry₹436.6Inferred
Target₹520
Total upside +19.10%
Stop lossNot given
CMP₹323.51d ago
Active-25.90%+60.74%upside left 10 mo left

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 24 Oct, 5:02 pm IST
32 supporting9 neutral4 opposing
Supports the BUY call (32)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·23 Oct · yesterday

Biocon settles licence agreement with Genetech for cancer treatment drug — Check earliest secured launch dates

NewsCnbc-Tv18·14 Oct · 1w ago

(opens in new tab)

Biocon Malaysia arm gets UK regulator approval for Semglee fill finish unit

NewsCnbc-Tv18·25 Sept · 4w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·19 Sept · 1mo ago

5 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·7 Aug · 3mo ago

Neutral / worth noting (9)

Nothing found in this tip’s window yet.

Weighs against the BUY call (4)

1 advisor has an active short-term SELL call on this stock

Advisor consensus · adjacent horizon·9 Oct · 2w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.